Pfizer Inc. stock falls Thursday, still outperforms market - MarketWatch

sank 0.30% to $36.75 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet

See our market data terms of use

"After a 150+% rise in the stock since the September direct listing, we believe the stock is vulnerable heading into 2021 with the upcoming lockup expiry, and an expected deceleration in growth

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy